Hedge Fund - Miller Value Partners

Teva Pharmaceutical Industries Ltd (TEVA) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $0 0% 0 $17.86
2 2024 - Q4 (2024-12-31) $241,338 0.1% 10,950 $18.19
3 2024 - Q3 (2024-09-30) $197,319 0.11% 10,950 $17.50
4 2024 - Q2 (2024-06-30) $177,937 0.11% 10,950 $15.40
5 2024 - Q1 (2024-03-31) $163,676 0.1% 11,600 $12.61
6 2023 - Q4 (2023-12-31) $139,896 0.08% 13,400 $9.34
7 2023 - Q3 (2023-09-30) $145,095 0.09% 14,225 $9.31
8 2023 - Q2 (2023-06-30) $618,492 0.4% 82,137 $8.11
9 2023 - Q1 (2023-03-31) $34,778,588 2.17% 3,929,784 $9.89
10 2022 - Q4 (2022-12-31) $46,940,886 3.02% 5,147,027 $8.73
11 2022 - Q3 (2022-09-30) $74,687,000 4.53% 9,254,875 $8.84
12 2022 - Q2 (2022-06-30) $70,196,000 3.56% 9,334,590 $8.71
13 2022 - Q1 (2022-03-31) $94,451,000 3.03% 10,058,739 $8.35
14 2021 - Q4 (2021-12-31) $77,373,000 2.11% 9,659,519 $9.03
15 2021 - Q3 (2021-09-30) $94,947,000 2.2% 9,748,129 $9.36
16 2021 - Q2 (2021-06-30) $108,265,000 2.57% 10,935,783 $10.58
17 2021 - Q1 (2021-03-31) $121,794,000 3.15% 10,554,065 $11.47
18 2020 - Q4 (2020-12-31) $68,898,000 2.09% 7,139,700 $9.58
19 2020 - Q3 (2020-09-30) $72,923,000 2.61% 8,093,698 $10.58
20 2020 - Q2 (2020-06-30) $96,796,000 4.29% 7,850,472 $11.31
21 2020 - Q1 (2020-03-31) $71,107,000 4.57% 7,918,362 $10.25
22 2019 - Q4 (2019-12-31) $96,374,000 3.41% 9,834,067 $8.93
23 2019 - Q3 (2019-09-30) $58,419,000 2.34% 8,491,152 $7.66
24 2019 - Q2 (2019-06-30) $59,997,000 2.28% 6,500,252 $12.06
25 2019 - Q1 (2019-03-31) $71,227,000 2.82% 4,542,532 $17.63
26 2018 - Q4 (2018-12-31) $60,320,000 2.73% 3,911,802 $20.50
27 2018 - Q3 (2018-09-30) $84,123,000 2.71% 3,905,452 $23.22
28 2018 - Q2 (2018-06-30) $62,955,000 2.35% 2,588,612 $20.39
29 2018 - Q1 (2018-03-31) $37,512,000 1.56% 2,194,972 $19.52
30 2017 - Q4 (2017-12-31) $9,780,000 0.41% 516,112 $15.04

The displayed share prices are average quarterly stock market prices.